Halting NDM-producing enterobacteriaceae spread with the reactive infection control strategy: a real-world experience analyzed using a novel spatiotemporal epidemiologic risk measure (Epi-score) and whole-genome sequencing (WGS) by unknown
ORAL PRESENTATION Open Access
Halting NDM-producing enterobacteriaceae
spread with the reactive infection control
strategy: a real-world experience analyzed using
a novel spatiotemporal epidemiologic risk
measure (Epi-score) and whole-genome
sequencing (WGS)
K Marimuthu1*, O Ng1, W Khong1, E Xia2, W Xu2, Y Teo2, E Tan2, RT Ong2, D Lye1, A Chow1, P Krishnan1, B Ang1
From 3rd International Conference on Prevention and Infection Control (ICPIC 2015)
Geneva, Switzerland. 16-19 June 2015
Introduction
Guidelines recommend screening of epidemiologically
linked patients to contain the spread of NDM-producing
enterobacteriaceae (NDM-EB).
Objectives
We assessed the effectiveness of this strategy in control-
ling the spread of NDM-EB using Epi-score and whole-
genome sequencing (WGS).
Methods
This study was conducted at Tan Tock Seng Hospital
(TTSH) between September 2010 and December 2011.
TTSH implemented a reactive infection control strategy
which constituted pre-emptive cohorting and rectal surveil-
lance of patients with epidemiological linkage (contacts) to
patients with NDM-EB isolated from clinical cultures
(index). A clinical transmission model was produced for
NDM-EB patients both from clinical and surveillance cul-
tures based on epidemiological relatedness. The Epi-score
graded epidemiologic-relatedness from 0 (unrelated) to
4 (very related), based on spatiotemporal ward overlap
(2 points), shared medical teams (1 point), and shared
medical department (1 point). This was the compared with
a molecular transmission model which was produced
using WGS of all NDM-EB isolates with core-genome
single-nucleotide polymorphism analysis after excluding
recombinant sites.
Results
A total of six index clinical NDM-EB were detected
(patients 1-3,5,7-8) (5 urine and 1 bile). Contact screening
as part of reactive strategy involved 436 patients, of which
2 (patients 4, 6) were newly-detected NDM-EB carriers.
Epi-score distributions: 3 points (patients 1-4,2-3,5-6);
2 points (patients 1-5,4-5), 1 point (patients 1-7,5-8,6-8).
Of the 3 point pairs, one (5-6) was confirmed direct trans-
mission by whole-genome phylogenetic analysis (4 SNVs).
None of the other patients were identified by WGS as
direct transmission. In six (75%) isolates, NDM was
carried on plasmid pTR3 which is unique to Singapore.
Conclusion
Only one direct ward transmission pair (confirmed by
whole-genome-sequencing) was detected by the reactive
strategy. The Epi-score performed well in classifying the
direct ward transmission pair in the highest relatedness
category. Most (75%) NDM-producing EB originated in
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